Your session is about to expire
← Back to Search
Radiation Therapy + Cisplatin for Head and Neck Cancer
Study Summary
This trial is testing whether radiation therapy is more effective with or without cisplatin in treating patients with squamous cell carcinoma of the head and neck.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your platelet count is at least 100,000 per cubic millimeter within 4 weeks before starting the study.My cancer is a type of squamous cell carcinoma in the head or neck, at stage III or IVA.I have registered for screening and submitted tissue samples after surgery.I've been cancer-free for 2 years, except for certain skin cancers or cervical pre-cancer.My cancer has not come back or spread from its original site.I had surgery to remove my cancer completely within the last 8 weeks.I had surgery to completely remove my cancer with the goal of curing it.My kidney function, measured by creatinine clearance, is good.I had certain medical tests done within the last 8 weeks.I am fully active or restricted in physically strenuous activity but can do light work.My white blood cell count is healthy.My oropharynx tumor is not caused by HPV.I haven't had radiation to my head or neck that would affect my current treatment area.I can send a tissue sample from my surgery to Foundation Medicine.I do not have any other illness that could affect my treatment.I am using or willing to use effective birth control during and up to 60 days after the study.Your total bilirubin level should be within the normal range before the study starts.
- Group 1: Arm A (IMRT)
- Group 2: Arm B (IMRT, cisplatin)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there vacancies available to participants in this trial?
"Affirmative, the data on clinicaltrials.gov showcases that this medical research is still searching for participants. Initially posted on March 29th 2016, and most recently updated June 9th 2022, 189 patients between 100 sites are needed."
What maladies can be alleviated through Cisplatin administration?
"Cisplatin is most popularly used to counter metastatic neoplasms, yet it may also be utilized in certain conditions such as advanced ovarian cancer that are unresponsive to traditional interventions."
How many individuals have enrolled in this clinical experiment?
"Affirmative. Data on clinicaltrials.gov indicates that this experiment, which was first posted on March 29th 2016, is still enrolling participants. Currently 189 patients need to be recruited from 100 different locations."
Has Cisplatin been sanctioned by the FDA?
"Due to a lack of supporting clinical evidence demonstrating its efficacy, Cisplatin has been provisionally rated with a score of 2 in terms of safety."
What other research endeavours have been conducted which concern Cisplatin?
"Currently, 747 studies are underway assessing the efficacy of Cisplatin while 289 of those trials have made it to Phase 3. Most of these experiments are located in Shanghai but 44132 locations around the world host research into this therapeutic agent."
How many locations is the implementation of this clinical trial taking place?
"100 medical centres are currently recruiting participants for this study. Among these locations include Livonia, Troy, and Boardman as well as other surrounding areas. For convenience's sake, it is recommended that prospective enrollees select the closest site to them in order to reduce travel demands."
Share this study with friends
Copy Link
Messenger